Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > NSCLC and GBM indications

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Dec 19, 2022 11:04am

214 Views

Post# 35179619

RE:RE:RE:RE:RE:RE:RE:NSCLC and GBM indications

Wildbird1... Excellent post.

Managing the kitty to preserve the reach of the ultimate objective is what any good management teams try to achieve.

______________

wildbird1 - (12/19/2022 10:38:39 AM)

RE:RE:RE:RE:RE:RE:NSCLC and GBM indications

Good post Eoganacht...

Here is a quote that you can find in almost every " Audited Financial Statement" since May 29, 2020.
This one is from April 28,2021 "Audited Financial Statement".
TLT said" The decrease in administrative expenses is primarily attributed to decrease spending on general and administrative expense(40%), director and advisory fees(45%) and administrative salaries(59%) due to COVID-19 pandemic, resulting in the termination of certain non-essencial administrative personnel.

That was a smart move by TLT to save money in difficult time.
Unfortunately some peoples on this board try to give that smart move a negative spin.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?